"Injectable ARVs will give me peace" women's acceptability of injectable antiretroviral therapy in prevention of HIV vertical transmission in Uganda.

ABSTRACT: A third of women who initiate or continue antiretroviral (ARV) treatment during pregnancy are lost- to- follow-up (LTFU) within six months in sub-Saharan Africa. Clinical trials of long acting injectable Antiretroviral Therapy (LA-ART) are ongoing, including for pregnant women. The study explored women's acceptability and attitudes towards- the use of potentially discreet LA-ART in Uganda for Prevention of Vertical Transmission Program (PVT). Understanding women's perspectives of LA-ART before its introduction is critical in answering questions about acceptability and identifying interventions for future implementation and uptake. In May 2022, we purposively selected participants for eight focus group discussions (FGDs) in 5 health facilities in Kampala: 5 with retained mothers and 3 with

SUBMITTER: Ekusai-Sebatta D 

PROVIDER: S-EPMC12267473 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature